News - TherapySelect

The trade magazine " Laborjournal" publishes an article about TherapySelect which is not available online unfortunataly. "Laborjournal" is sent to scientific institutions free of charge and can be ordered by companies after subscription and payment of a small fee.

<>The project management Jüllich announces the funding for the Predictor-Study. The necessary Ethics Committee votes will be reeled in and potentially participating centers will be contacted. Therfore the clinics will start the recruitment of patients soon.

<>In 2011, the test unindebtedly lost NUB status 1. Unfortunately, this didn't change in 2012 even though 228 clinics made an application for cost absorption and there is a particular OPS-key from the German Institution for Medical Documentation and Information (DIMDI). This OPS-key is 1-990...

<>TherapySelect is present on the German Cancer Congress. The CTR-Test<> was presented with a flyer. This flyer is available for download on this web page in the section Downloads.

<>Due to the change in TherapySelect's address, the web page and all official documents found in the Downloads section are updated.

We moved into a new laboratory to guarantee a high level of quality while performing the CTR-Test ® . Therefore, the address changed which was updated on the website.

<>This year, the deadline of the Institute for the Hospital Remuneration System (InEK) for NUB (new examination and treatment methods) requests ends on October 31, 2011 as well. Requests which are submitted after that date will not be accepted by the InEK. By submitting a NUB request, the...

This year, the deadline of the Institute for the Hospital Remuneration System (InEK) for NUB (new examination and treatment methods) requests ends on October 31, 2010 as well. Requests which are submitted after that date will not be accepted by the InEK. By submitting a NUB request, the clinic will...

<>The new registration tool (NUB.exe) for new examination and treatment methods (NUB) is available at the Institution for the Hospital Remuneration System (InEK GmbH). You can complete NUB requests for 2011 with the help of the registration tool before e-mailing them to the InEK ( NUB@inek-...

<>Due to the vivid request, TherapySelect will provide further training courses for clinics and specialized departments in the field of functional cancer diagnostics (focus on sensitivity testing for chemotherapeutic agents) in future. The events usually consist of a scientific lecture and a...

<>Personalized medicine is still an extensive topic, also in anticancer therapy. The issue was set in motion because data collections from the past decades have shown that targeted therapies for each patient in combination with modern surgery techniques, diagnostics and medicine lead to...

This year the Chemotherapy-Resistance-Test (CTR-Test ® ) receives NUB (new examination and treatment methods) status 1 from the Institution for the Hospital Remuneration System (InEK GmbH) as well. It has received this status every year since the first application in 2007. The CTR-Test ® currently...

Since this year's opening of the European reference laboratory in Heidelberg all of the services of the TherapySelect GmbH & Co. KG are performed in Germany. In terms of this change the name could also be adjusted to the German market. Therefore we chose CTR-Test ® (Chemotherapy-Resistance-Test...

Within the context of the meeting of the project group ovarian cancer of the Nord-Ostdeutsche Gesellschaft für GynäkologischeOnkologie (NOGGO, North-East German society for gynecological oncology) e.V. the meeting of the Predictor-Study was held in Berlin on March 19th, 2009. The Predictor-Study...

03/2009 – Journal Onkologie (p. 134 ff.) An interview with Prof. Dr. med. Jalid Sehouli about "Chemotherapy-Resistance-Test (EDR ® -Test) - A New Aid in Oncology Treatment of Recurrent Tumors?" Interview with Prof. Dr. med. Jalid Sehouli (only in German)

As in the past years, the Chemotherapy-Resistance-Test (CTR ® -Test) received NUB (new examination and treatment methods) status 1 from the Institution for the Hospital Remuneration System (InEK GmbH). This entitles the clinics, which submitted a NUB request for the EDR ® -Test, to arrange a...

On the occasion of the 12th congress of the IGCS (International Gynecologic Cancer Society) in Bangkok, results of the EORTC study 55971 were presented. On the basis of 246 female patients with ovarian cancer, this double blind study was able to show that in vitro resistance to platinum...